Focused Ultrasound as a Scalable and Contact-Free Method to Manufacture Protein-Loaded PLGA Nanoparticles.

Schiller, Stefan; Hanefeld, Andrea; Schneider, Marc; Lehr, Claus-Michael

dc.contributor.author	Schiller, Stefan
dc.contributor.author	Hanefeld, Andrea
dc.contributor.author	Schneider, Marc
dc.contributor.author	Lehr, Claus-Michael
dc.date.accessioned	2015-09-24T08:32:31Z	en
dc.date.available	2015-09-24T08:32:31Z	en
dc.date.issued	2015-09	en
dc.identifier.citation	Focused Ultrasound as a Scalable and Contact-Free Method to Manufacture Protein-Loaded PLGA Nanoparticles. 2015, 32 (9):2995-3006 Pharm. Res.	en
dc.identifier.issn	1573-904X	en
dc.identifier.pmid	25823648	en
dc.identifier.doi	10.1007/s11095-015-1681-7	en
dc.identifier.uri	http://hdl.handle.net/10033/578673	en
dc.description.abstract	Although nanomaterials are under investigation for a very broad range of medical applications, only a small fraction of these are already commercialized or in clinical development. A major challenge for the translation of nanomedicines into the clinic is the missing scalability of the available lab scale preparation methods and, ultimately, non-identical samples during early and late research.
dc.language.iso	en	en
dc.title	Focused Ultrasound as a Scalable and Contact-Free Method to Manufacture Protein-Loaded PLGA Nanoparticles.	en
dc.type	Article	en
dc.contributor.department	Helmholtz Institute for Pharmaceutical Research Saarland,Saarbru¨ cken, Saarland 66123, Germany.	en
dc.identifier.journal	Pharmaceutical research	en
refterms.dateFOA	2016-09-15T00:00:00Z
html.description.abstract	Although nanomaterials are under investigation for a very broad range of medical applications, only a small fraction of these are already commercialized or in clinical development. A major challenge for the translation of nanomedicines into the clinic is the missing scalability of the available lab scale preparation methods and, ultimately, non-identical samples during early and late research.